NCT05503433

Brief Summary

Objective: This study was designed to determine whether maternal cortisol levels affect fetal heart rate (FHR) patterns at third trimester. Design: Cross-sectional descriptive study. Setting: Prenatal wards of 1 public maternity services in Istanbul, Turkey. Participants: This study included 400 nulliparous pregnant women with uncomplicated pregnancies with a single fetus, between October 2022 and December 2022. Measurements and Findings: The minimum sample size required in the study was decided by power analysis. Effect size in the calculation: 0.35, type 1 error rate (α)=0.05, power of the study (1- β) 0.95 (Type II error=0.05) taken as. Accordingly, the minimum number of samples to be reached was calculated as 356 in total, and it was aimed to reach 392 samples, taking into account the 10% risk of loss. Research data will collect with the Data Collection Form. Noise level will measure with the Personal Noise Dosimeter. The FHR data will collect using a cardiotocograph. Saliva cortisol will measure by a microplate reader with commercially available kit based on ELISA.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
392

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2022

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 8, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 16, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

October 1, 2022

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

August 16, 2022

Status Verified

August 1, 2022

Enrollment Period

1 month

First QC Date

August 8, 2022

Last Update Submit

August 15, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Maternal cortisol level of the pregnant women

    About 5 ml of maternal saliva for cortisol measurements will collect at 08:00 -10:00 h and store at -80 °C until analysis. Saliva cortisol will measure by a microplate reader (Thermo Scientific Multiskan FC, 2011-06, USA) with commercially available kit based on ELISA (Human Salivary Cortisol ELISA kit-DRG international, Inc., USA, Cat Num:slv-2930).

    01.02.2021-01.10.2021

Secondary Outcomes (1)

  • Fetal heart rate measurement

    01.02.2021-01.10.2021

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsNulliparous pregnant women
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

In all patients, well-being and growth of the fetus should be normal and amniotic fluids were also normal.

You may qualify if:

  • Voluntarily agreeing to participate in the research,
  • Over 18 years old,
  • Literate,
  • Speaks Turkish,
  • In the third trimester of pregnancy,
  • Having a healthy pregnancy,
  • No adrenal insufficiency,
  • No problems with hearing,
  • No psychiatric diagnosis during or before pregnancy,
  • No history of infertility,
  • Coming to routine pregnancy and NST control,
  • Have not had any food or drink for at least two hours before the procedure,
  • Nulliparous pregnant women without contractions were included.

You may not qualify if:

  • Pregnant women whose contractions are detected while the NST procedure is in progress,
  • Pregnant women with deceleration detected in the NST procedure were excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Turan A, Kaya C. Effect of maternal cortisol levels on fetal heart rate patterns in primiparous pregnant women in the third trimester. Rev Assoc Med Bras (1992). 2023 May 19;69(5):e20221610. doi: 10.1590/1806-9282.20221610. eCollection 2023.

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 8, 2022

First Posted

August 16, 2022

Study Start

October 1, 2022

Primary Completion

November 1, 2022

Study Completion

December 1, 2022

Last Updated

August 16, 2022

Record last verified: 2022-08